首页 | 官方网站   微博 | 高级检索  
     

P53、C-erbB-2和VEGF在胃癌中的表达及其临床意义
引用本文:张志强,姜林,李斌,盛黎黎.P53、C-erbB-2和VEGF在胃癌中的表达及其临床意义[J].武警医学院学报,2010,19(7):513-515,F0004.
作者姓名:张志强  姜林  李斌  盛黎黎
作者单位:1. 武警湖北总队医院,病理科,湖北,武汉,430061
2. 武警湖北总队医院,消化内科,湖北,武汉,430061
摘    要::目的]分析P53、C-erbB-2、VEGF在胃癌组织中的表达与胃癌临床病理特征之间的关系.方法]收集我院2006年1月-2007年12月经手术切除且病理证实的胃癌病例,记录各患者分化程度、浸润程度、淋巴结转移情况及TNM分期.获得临床资料完整的病例60例,复习病理大体及镜下特点,行免疫组化染色,观察P53、C-erbB-2、VEGF在胃癌组织中的表达情况.结果](1)P53基因蛋白在胃癌组织中表达阳性率为60%,P53基因蛋白阳性表达与分化程度、有无淋巴结转移有关.(2)C-erbB-2基因蛋白在胃癌组织中表达阳性率为73.3%.C-erbB-2基因蛋白阳性表达与与浸润程度及淋巴结是否转移有关).(3)VEGF在胃癌组织中表达阳性率为75%.VEGF阳性表达与浸润深度、淋巴结是否转移及临床分期有关.结论]联合检测P53、C-erbB-2及VEGF在胃癌组织中的表达对胃癌的临床诊断、病情评估、治疗及预后可提供一定指导.

关 键 词:胃癌  P53蛋白  C—erbB-2蛋白  血管内皮生长因子

Expression of P53,C-erbB-2 and VEGF in gastric cancer and the clinical significance
ZHANG Zhi-qiang,JIANG Lin,LI Bin,SHENG Li-li.Expression of P53,C-erbB-2 and VEGF in gastric cancer and the clinical significance[J].Acta Academiae Medicinae CPAPF,2010,19(7):513-515,F0004.
Authors:ZHANG Zhi-qiang  JIANG Lin  LI Bin  SHENG Li-li
Affiliation:(Department of Pathology, Hubei Provincial Corps Hospital of Chinese People's Armed Police Force, Wuhan 430061,China)
Abstract:Objective] By analyzing the relationship between P53, C-erbB-2 and VEGF expression in gastric cancer and clinical features of gastric cancer,to help accurate determination the patient's condition and prognosis. Methods] By collecting surgically reseeted and pathologically confirmed cases of gastric cancer,get 60 cases of complete clinical data. To observe P53, C-erbB-2 and VEGF expression in gastric cancer, and to analyse by using SPSS 10.0 statistical software. Results] Positive rate of P53 gene expression in gastric cancer was 60%. P53 gene expression was positively correlated with the differentiation and lymphaden metastases. Positive rate of C-erbB-2 gene expression in gastric cancer was 73.3 %. C-erbB-2 gene expression was positively correlated with the extension and lymphaden metastases. Positive rate of VEGF expression in gastric cancer was 75 % .VEGF expression was positively correlated with the extension, lymphaden metastases and clinical stages. Conclusion] Combined detection of the expression of P53, C-erbB-2 and VEGF in gastric cancer may give some guideline for the clinical diagnosis ,illness evaluation ,treatment and prognosis of gastric cancer.
Keywords:Gastric cancer  P53  C-erbB-2  VEGF
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号